Literature DB >> 12409076

Fulvestrant versus anastrozole as second-line treatment of advanced breast cancer in postmenopausal women.

I Vergote1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12409076     DOI： 10.1016/s0959-8049(02)00287-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

Review 1.  Breast cancer management in the elderly.

Authors:  M Luque; F Arranz; J F Cueva; A de Juan; P García-Teijido; L Calvo; I Peláez; A García-Palomo; J García-Mata; S Antolín; L García-Estévez; Y Fernández
Journal:  Clin Transl Oncol       Date:  2013-10-02       Impact factor: 3.405

Review 2.  Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.

Authors:  Lorna Gibson; David Lawrence; Claire Dawson; Judith Bliss
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

3.  Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer.

Authors:  Jiayu Wang; Binghe Xu; Peng Yuan; Fei Ma; Qing Li; Pin Zhang; Ruigang Cai; Ying Fan; Yang Luo; Qiao Li
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 4.  From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same Target.

Authors:  Madhusoodanan Mottamal; Borui Kang; Xianyou Peng; Guangdi Wang
Journal:  ACS Omega       Date:  2021-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.